Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?

BACKGROUND: Current therapy for the treatment of neuropathic pain is often unsatisfactory. Considerable variation in treatment pattern still exists in spite of availability of sufficient literature from various guidelines. Recent Indian market data suggested that the utilization (sale) of drugs such...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamble, Sanjay Vasant, Motlekar, Salman Abdulrehman, D'souza, Lyndon Lincoln, Kudrigikar, Vinay Nanda, Rao, Sameer Eknath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532525/
https://www.ncbi.nlm.nih.gov/pubmed/28757918
http://dx.doi.org/10.3344/kjp.2017.30.3.183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532525/
https://www.ncbi.nlm.nih.gov/pubmed/28757918
http://dx.doi.org/10.3344/kjp.2017.30.3.183

Ejemplares similares